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Limited access to human islets has prompted the development of human beta cell models. The human 
beta cell lines EndoC-βH1 and EndoC-βH2 are increasingly used by the research community. However, 
little is known of their electrophysiological and secretory properties. Here, we monitored parameters 
that constitute the glucose-triggering pathway of insulin release. Both cell lines respond to glucose 
(6 and 20 mM) with 2- to 3-fold stimulation of insulin secretion which correlated with an elevation 
of [Ca2+]i, membrane depolarisation and increased action potential firing. Similar to human primary 
beta cells, KATP channel activity is low at 1 mM glucose and is further reduced upon increasing glucose 
concentration; an effect that was mimicked by the KATP channel blocker tolbutamide. The upstroke 
of the action potentials reflects the activation of Ca2+ channels with some small contribution of TTX-
sensitive Na+ channels. The repolarisation involves activation of voltage-gated Kv2.2 channels and 
large-conductance Ca2+-activated K+ channels. Exocytosis presented a similar kinetics to human 
primary beta cells. The ultrastructure of these cells shows insulin vesicles composed of an electron-
dense core surrounded by a thin clear halo. We conclude that the EndoC-βH1 and -βH2 cells share many 
features of primary human β-cells and thus represent a useful experimental model.
Electrical activity plays a critical role in glucose-stimulated insulin secretion (GSIS)1,2. An understanding of the 
stimulus-secretion coupling in beta-cells is important as its dysfunction is recognised to be a central feature of 
Type 2 Diabetes (T2D)3,4. Indeed, the majority of genome-wide association study (GWAS) loci identified to date 
for T2D affect beta-cell function and/or mass5,6. However, exactly how these variants impact beta-cell function 
has only been established for a handful of them.
The limited availability of human islets preparations coupled with donor variability has hampered the study 
of human beta-cell function. Consequently, determining how genetic variants and the transcripts they exert 
their effect on influence beta-cell function remains a challenging topic to explore. Therefore, access to a human 
beta-cell line amenable to genetic modification would be extremely valuable. The EndoC-βH1 and -βH2 cells 
were generated from human foetal pancreatic buds and express numerous beta-cell markers. These human 
beta-cell lines respond to elevated glucose with stimulation of insulin secretion7,8 and are increasingly used to 
explore various aspects of human beta-cell biology9–21.
Here, we monitored different parameters that constitute the triggering pathway of GSIS1,22 and the electro-
physiological and ultrastructural properties of EndoC-βH1 and -βH2 cells. We correlate our electrophysiological 
characterisation with global gene transcript levels for both cell lines. Overall, our data show consistency between 
the EndoC-βH1 and -βH2 cells and primary human beta-cells, supporting their use as a valuable model system.
1Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Radcliffe Department of Medicine, University 
of Oxford, Oxford, United Kingdom. 2Wellcome Centre for Human Genetics, Nuffield Department of Medicine, 
University of Oxford, Oxford, United Kingdom. 3INSERM U1016, Cochin Institute, Université Paris Descartes, Paris, 
France. 4National Institute for Health Research (NIHR) Oxford Biomedical Research Centre, Churchill Hospital, 
Oxford, United Kingdom. 5Department of Physiology, Institute of Neuroscience and Physiology, University of 
Goteborg, Goteborg, Sweden. Correspondence and requests for materials should be addressed to B.H. (email: 
benoit.hastoy@ocdem.ox.ac.uk)
Received: 4 June 2018
Accepted: 19 October 2018
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific REPORTS |         (2018) 8:16994  | DOI:10.1038/s41598-018-34743-7
Methods
Ethics. Human pancreatic islets were isolated from deceased donors under ethical approval obtained from 
the human research ethics committees in Oxford (REC: 09/H0605/2, NRES committee South Central-Oxford B). 
All donors gave informed research consent as part of the national organ donation programme. Islets were 
obtained from the Diabetes Research & Wellness Foundation Human Islet Isolation Facility, OCDEM, University 
of Oxford. All methods and protocols using human pancreatic islets were performed in accordance with the rel-
evant guidelines and regulations in the UK (Human Tissue Authority, HTA).
Cell lines and cell culture. EndoC-βH1 and -βH2 cell lines, both generated from human fetal pancreatic 
buds were provided by Endocell and Raphael Scharfmann7,8. Both cell lines were regularly tested for mycoplasma 
contamination and cultured as previously published8. Additional details are available in the Supplementary 
material.
Insulin Secretion. EndoC-βH1 and βH2 cells were seeded onto coated 24 well plates at a density of 300,000 
cells/well. The night before experiment, the cells were incubated in 2.8 mmol/L glucose culture medium. Prior 
to the experiment, the cells were incubated in a modified Krebs-Ringer buffer (KRB) medium consisting of 
(mmol/L) 138 NaCl, 3.6 KCl, 0.5 MgSO4, 0.5 NaH2PO4, 5 NaHC03, 1.5 CaCl2 and 5 HEPES (adjusted to pH 
7.4 with NaOH) and supplemented with 0.2% w/v BSA. The cells were washed with the glucose-free medium, 
preincubated for 15 min at 1 mmol/L glucose before a 40 min test incubation at either 1, 6 or 20 mmol/L glucose 
and with added tolbutamide (0.2 mmol/L) or diazoxide (0.5 mmol/L) as indicated. Supernatants (0.3 ml) were 
taken for determination of insulin release. Cellular insulin content was extracted by acid ethanol treatment. The 
samples were frozen pending later analysis which was carried out using commercial ELISA (Alpha Laboratories) 
or radioimmunosassay (HI-14 K, Merck). Insulin secretion is expressed as a percentage of cellular insulin content 
and fold-increase in secretion as a ratio with basal secretion (1 mmol/L). The somatostatin receptor 2 (SSTR2) 
antagonist CYN154806 was obtained from TOCRIS (Abingdon, UK).
Electrophysiology. All electrophysiological experiments were performed as described previously23. 
Agatoxin, isradipine, SNX 482, stromatoxin and iberiotoxin were purchased from Alomone (Jerusalem, Israel) 
and tetrodotoxin (TTX) from Sigma (Gillingham, UK).
Solutions. All electrophysiological experiments were performed at 32 °C in a standard or perforated patch whole 
cell configuration. Recordings were made using an EPC-10 amplifier and Pulse software. The action potential-like 
voltage-clamp commands were constructed by averaging 12 and 15 action pontential in EndoC-βH1 and 
EndoC-βH2, respectively and used to elicit currents. Action potentials were also recorded from human primary 
beta cells to allow comparison with action potential shape in the two cell lines.
For the perforated patch recordings and measurements of K+ current, the extracellular medium was com-
posed of (mmol/L) 138 NaCl, 3.6 KCl, 0.5 MgSO4, 0.5 NaH2PO4, 5 NaHC03, 1.5 CaCl2 and 5 HEPES (pH 7.4 
with NaOH). The extracellular medium was supplemented with 1, 6 or 20 mmol/L glucose and tolbutamide 
(0.2 mmol/L) and diazoxide (0.5 mmol/L) as indicated. For the measurements of Na+ and Ca2+ currents and 
capacitance measurement of exocytosis, outward K+ currents were inhibited by inclusion of 20 mmol/L tetraeth-
ylammonium (TEA) in the extracellular medium (NaCl correspondingly reduced to maintain iso-osmolarity). 
Na+ currents were recorded after substitution of CaCl2 for CoCl2 (to block the voltage-gated Ca2+ currents).
Various pipette-filling media were used. For the perforated patch measurements, the pipette-filling medium 
contained (mmol/L) 128 K-gluconate, 10 KCl, 10 NaCl, 1 MgCl2 and 10 HEPES (pH 7.35 adjusted with KOH). 
Perforation of the membrane was achieved using amphotericin B (0.24 mg/ml)24. For the capacitance measure-
ments of exocytosis, the intracellular medium contained (mmol/L) 129 CsOH, 125 Glutamic acid, 20 CsCl, 15 
NaCl, 1 MgCl2, 0.05 EGTA, 3 ATP, 0.1 cAMP, 5 HEPES (pH7.2 with CsOH). For recordings of the voltage-gated 
K+ currents, the pipette was filled with (mmol/L) 120 KCl, 1 MgCl2, 1 CaCl2, 3 MgATP, 10 EGTA, 10 HEPES (pH 
7.15 with KOH). A similar medium was used for the Na+ and Ca2+ currents measurements except that KCl was 
equimolarly replaced by CsCl and pH adjusted with CsOH.
Current analysis. The net contribution of a current component to the total current was estimated by subtracting 
the current responses after addition of specific blockers from those observed prior to the addition. In experiments 
involving multiple blockers, these were applied sequentially in the continued presence of the other inhibitor(s). To 
compensate for variations in cell size, responses have been normalised to cell capacitance, which is proportional 
to cell surface area. Compared to primary human beta-cells, both cell lines appear more fragile and it was difficult 
to maintain the recordings long enough to allow sequential application of multiple channel blockers.
Sodium channels activation/inactivation. The voltage dependence of activation by fitting to the Boltzmann equa-
tion (Eq. 1) the increased conductance normalised to its maximum evoked from a voltage of −70 to 20 mV:
= −
+ − .( )
y 1 1
1 exp (1)
x V
dx
0 5
where V0.5 is the membrane potential at which activation is half-maximal and dx is the slope.
Monophasic inactivation of the Na+ current was fitted to a single Boltzmann equation (Eq. 2):
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where Vh is the voltage at which current inactivation is half-maximal, and x is the slope factor.
[Ca2+] imaging. The cells were plated at the same density as that in the culture flask but in a 60 μl strip on 
the coverslip. EndoC-βH1 and –βH2 cells were transfected with GCaMP5G, expressed from pCMV-GCaMP5G 
(Addgene plasmid # 31788) using lipofectamine (ThermoFischer Scientific, Loughborough) as detailed in the 
Supplementary material. Prior to experiments, the coverslip was transferred to an in-house recording chamber, 
superfused at a rate of 60 μl/min with KRB solution at 34 °C and imaged using a 10–14x magnification on a Zeiss 
AxioZoom.V16 microscope (Zeiss, Germany). Synchronisation of the recording with the perfusion is achieved 
by addition of food colorant to the superfusion medium at the end of the experiment. Image sequences were ana-
lysed as detailed in the Supplementary material.
Immunocytochemistry. EndoC-βH1 and -βH2 were fixed in 4% paraformaldehyde, permeabilised in 0.1% 
(v/v) Triton X-100, and blocked in 5% (w/v) goat serum. Immunofluorescence was performed using a guine-
apig anti-insulin antibody directed against human B chain (in-house, 1:1000) and anti-guineapig Texas red sec-
ondary antibody. Glucagon and somatostatin were labeled using anti-mouse glucagon antibody (Sigma, 1:1000) 
and anti-mouse somatostatin antibody (Santa Cruz Biotechnology, Germany, 1:200). Both were detected using 
an anti-imouse FITC secondary antibody and mounted in Vectashield Mounting Medium with DAPI (Vector 
Laboratories). Cells were imaged using an LSM 510 META confocal laser scanning module arranged on an 
Axiovert 200 microscope and a Plan-Apochromat 63x/1.4 oil immersion objective (Carl Zeiss). An argon laser 
was used to excite at λ = 488 nm and a HeNe laser was used to excite Texas red at λ = 543 nm. DAPI was excited 
in two-photon mode using the 740 nm line of an infrared light Chameleon laser. Proportion of SST/GLC positive 
cells were determined using FIJI software.
Electron microscopy. EndoC-βH1 and -βH2 cells cultured either in flasks or on a 0.4 μm polycarbonate 
membrane (Nunc, #137052) were fixed in 2.5% glutaraldehyde, post-fixed in 2% uranyl acetate, dehydrated 
in graded methanol, and embedded in London Resin Gold (Agar Scientific, Stansted, UK). Ultrathin sections 
(70 nm) cut onto nickel grids were immunolabelled with anti-glucagon (Sigma, 1:100) or anti-somatostatin 
(Santa Cruz Biotechnology, #25262, 1:10) followed by anti-rabbit biotin (Vector Laboratories, Peterborough) and 
streptavidin gold 15 nm (British Biocell International, Cardiff, UK). Insulin was immunolabelled (DAKO, Ely, 
UK, 1:500) followed by anti-guinea pig gold 10 nm (British Biocell International). Sections were viewed on a Joel 
1010 microscope (accelerating voltage 80 kV) with a digital camera (Gatan, Abingdon). The analysis is detailed 
in the Supllementary material.
Morphology. The granule density (NA) can be converted to the volume density (NV) using the equation 
(Eq. 3):
=
+ −
N N
T D h( 2 ) (3)V
A
where D is the measured averaged granule diameter, h is the smallest granule diameter and T the section thick-
ness. From the average vesicle area, the average diameter (D) was estimated as 0.2 μm. The smallest vesicle diame-
ter detected was 0.025 µm (h) which corresponds to Nv values of ~13 and 20 vesicles per μm3 in EndoC-βH1 and 
βH2, respectively.
RNA sequencing. For both cell lines, RNA was extracted using TRIzol and sequenced at the Oxford 
Genomics Centre (Wellcome Centre for Human Genetics, University of Oxford)25,26. These data are deposited 
at the European Nucleotide Archive (https://www.ebi.ac.uk/ena) under the accession number PRJEB23293 (a 
summary of the transcriptome analysis can also be found in Supplementary dataset). Details are found in the 
Supplementary material. Gene counts were quantified using featureCounts v1.5.0-p2)26, and converted into TPM 
(Transcripts Per kilobase Million).
Data analysis. Data are presented as mean ± SEM. The number of experiments (n) and details of the statis-
tical analysis are in the figure legends. P values are in the corresponding section in the results. For electrophys-
iology, calcium imaging, microscopy, n are representative of the number of cells from several passages of the 
same batch. For insulin secretion assay, n are representative of independent experiments performed at different 
passages from at least two different batches of cells. For each hormone secretion experiment, stimulations were 
performed in technical triplicates.
Results
Glucose-induced insulin release in EndoC-βH1 and -βH2 cells. Insulin secretion at 1 mmol/L glu-
cose (normalised to insulin content) was ~4.5% per hour (h) and ~3%/h in EndoC-βH1 and -βH2 cells (n = 3 
independent experiments), respectively (Fig. 1a). Increasing glucose to 6 mmol/L, stimulated insulin secretion by 
3-fold in EndoC-βH1 (p = 0.006) and by 1.5-fold in the EndoC-βH2 cells (p = 0.242) (Fig. 1b). Whereas elevating 
glucose to 20 mmol/L had no additive effect in EndoC-βH1 (p = 0.003), it resulted in a further 50% stimulation 
in EndoC-βH2 cells (p = 0.006). In both cell types, the stimulatory effect of glucose was prevented by the KATP 
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Figure 1. Glucose-induced insulin secretion and [Ca2+]i in EndoC-βH1 and -βH2 cells. (a) Basal insulin 
secretion elicited by 1 mmol/L glucose for 1 hour normalised to insulin content in EndoC-βH1 (black) and 
-βH2 (red). n = 3 independent experiments. (b) Insulin secretion normalised to basal stimulated during 40 min 
at 1, 6 or 20 mmol/L glucose and tolbutamide or diazoxide as indicated (n = 3). * and #p < 0.05, comparison 
to 1 mmol/L and 20 mmol/L glucose respectively, ** and ##p < 0.01 (ANOVA and Tukey). (c) Representative 
[Ca2+]i responses (normalised to initial fluorescence; F/F0) to 20 mmol/L glucose and 0.2 mmol/L tolbutamide, 
EndoC-βH1 (left) and -βH2 (right). Shown below are heatmaps from ≥120 cells from the same session 
(synchronized to representative traces) and displayed as F/F0 (colour scale at the bottom). (d) Quantification of 
the area under the curve (AUC) per minute for each condition over 4 and 3 sessions for EndoC-βH1 and -βH2 
respectively; ***p < 0.001, paired t-test.
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channel activator diazoxide (0.5 mmol/L) (EndoC-βH1 p = 0.003, EndoC-βH2 p = 0.002) and mimicked (in part) 
by the KATP channel blocker tolbutamide (0.2 mmol/L) (EndoC-βH1 p = 0.52, EndoC-βH2 p = 0.016) (Fig. 1b).
Transcriptomic analysis of these cell lines obtained by RNA-sequencing revealed that key genes involved in 
the beta-cell glucose sensing are expressed in these cell lines. The KATP channels subunits KCNJ11 (Kir6.2) and 
ABCC8 (SUR1) as well as SLC2A1 (encoding for the glucose transporter GLUT1) and GCK (glucokinase) are 
expressed at comparable levels in EndoC-βH1 and -βH2 (Supplementary Fig. 1 and Supplementary dataset). 
Whilst SLC2A2 (GLUT2) is expressed at levels approaching SLC2A1 in EndoC-βhH1 cells, its expression is very 
low in EndoC-βH2 cells (Supplementary Fig. 1 and Supplementary dataset).
Glucose triggers increases in [Ca2+]i in EndoC-βH1 and -βH2 cells. Insulin is secreted in response 
to an elevation in cytoplasmic Ca2+ ([Ca2+]i). We correlated the insulin secretion data to changes in [Ca2+]i 
in cells transfected with the genetically encoded Ca2+ indicator GCaMP5 (Fig. 1c). The heatmaps below the 
traces (GCamp5 fluorescence normalised to basal fluorescence; F/F0) illustrate the substantial heterogeneity 
between cells. Basal activity was higher in EndoC-βH1 than in EndoC-βH2 cells. Spontaneously active cells 
responded poorly to both high glucose and tolbutamide (bottom part of the heatmap). However, despite the 
variability, significant [Ca2+]i increases were evoked by both 6 mmol/L (n = 523 cells p = 7.6 × 10−47 and n = 225 
cells p = 9.2 × 10−22) and 20 mmol/L glucose (n = 442 cells p = 1.7 × 10−9 and n = 236 cells p = 3.1 × 10−13) or 
200 µmol/L tolbutamide (n = 965 cells p = 6.5 × 10−88 and n = 461 cells p = 3.0 × 10−19) in each cell line (for 
EndoC-βH1 and -βH2 respectively) (Fig. 1d).
EndoC-βH1 and -βH2 cells are electrically excitable. We correlated insulin secretion and changes 
in [Ca2+]i with electrical activity. At 1 mmol/L glucose, the membrane potential was −70 to −60 mV and many 
EndoC-βH1 and -βH2 cells exhibited spontaneous action potential firing. Increasing glucose concentrations to 
20 mmol/L resulted in membrane depolarisation to −55 mV and stimulation of electrical activity (Fig. 2a). On 
average, glucose (20 mmol/L) increased action potential frequency by 30- (n = 3 cells, p = 0.03) and 25-fold (n = 4 
cells, p = 0.01) in EndoC-βH1 and -βH2 cells, respectively (Fig. 2b). The characteristics of glucose-induced action 
potentials in EndoC-βH2 were largely similar to those in primary human beta-cells potential and peaked at 5 mV 
(Fig. 2c). However, in EndoC-βH1 cells, the action potentials were generally broader and in 90% of the measured 
cells, they peaked at voltages above +5 mV.
The resting membrane conductance (Gm) averaged 50–60 pS/pF (EndoC-βH1: n = 21 cells; EndoC-βH2: 
n = 22 cells) in both cell types (Fig. 2d). These values are in good agreement with membrane conductance meas-
ured in primary human beta-cells1. High glucose and tolbutamide reduced Gm by ≈50% (EndoC-βH1: n = 8 
cells, p = 0.003 and n = 3 cells p = 0.001; EndoC-βH2: n = 8 cells, p = 6.4 × 10−7 and n = 5, p = 8.63 × 10−5, 
respectively) (Fig. 2e). Conversely, addition of the KATP channel activator diazoxide (0.5 mmol/L) in the presence 
of 20 mmol/L glucose increased Gm by 200–400% (EndoC-βH1: n = 6 cells, p = 0.01; EndoC-βH2: n = 4 cells, 
p = 0.01). The average cell capacitance (proportional to the cell size) is of 10.6 pF and 12.5 pF for EndoC-βH1 and 
-βH2 (n = 30 and 32 cells, p = 0.04), respectively (Fig. 2f).
Voltage-gated channels. We next characterised the three voltage-gated membrane currents (Na+, Ca2+ 
and K+) that underlie action potentials.
Na+ channels. In both cell lines, voltage-gated Na+ currents (INa) elicited by membrane depolarisations from 
−70 to 0 mV were insensitive to the Ca2+ channel blocker Co2+ but highly blocked by tetrodotoxin (TTX, a 
blocker of most voltage-gated sodium channels) (Fig. 3a). Figure 3b shows families of Na+ currents during depo-
larisations between −60 and +20 mV evoked from a holding potential of −150 mV or −70 mV. Both activa-
tion and inactivation became more rapid with stronger depolarisations. At 0 mV, activation and inactivation 
were complete within <1 ms and 5 ms, respectively. Figure 3c shows the current (I)-voltage (V) relationships 
recorded when the cells were held at either −70 mV or −150 mV. In both cell types, INa became detectable during 
depolarisations to −40 mV, was maximal at 0 mV and decreased at more positive voltages with an extrapolated 
reversal potential at +70 mV. The maximum current elicited from −70 mV (−9.5 ± 1 pA/pF, n = 24 EndoC-βH1 
cells and −19 ± 7 pA/pF, n = 11 EndoC-βH2 cells) increased by 90% and 60% respectively when the cells were 
held at −150 mV (Fig. 3c). This suggests that the Na+ channels in EndoC-βH1 and –βH2 cells undergo partial 
voltage-dependent steady-state inactivation at unphysiologically negative membrane potentials, in agreement 
with what is observed in other insulin-secreting cells27.
We described the voltage dependence of activation from −70 mV by fitting the I–V relationship to Eq. 1. 
Activation of INa was half-maximal (V0.5) at −18 ± 0.3 mV (n = 26) and −19 ± 0.4 mV (n = 23) in EndoC-βH1 
and EndoC-βH2 cells, respectively (Fig. 3d).
Voltage-gated Na+ channels characteristically undergo voltage-dependent inactivation. We characterised this 
by a two-pulse protocol (a standard test pulse was preceded by a conditioning prepulse). In EndoC-βH1 and -βH2 
cells 58% and 36% of the measured INa exhibited monophasic inactivation; half-maximal inactivation (Vh; see Eq. 2 
in Supplementary material) was at −63 ± 2 mV (n = 15) and −59 ± 2 mV (n = 12) in EndoC-βH1 and -βH2 cells, 
respectively (Fig. 3e). The remaining cells showed biphasic voltage dependence of inactivation and in addition 
to the main component contained a current component that accounted for 30–40% of the total current that 
inactivated with Vh-values of −94 ± 4 mV (n = 11) to −91 ± 3 mV (n = 21) (not shown). The latter component 
likely accounts for the increase in INa amplitude when the cells were held at −150 mV rather than −70 mV, but its 
functional significance remains obscure, as it will be completely inactivated at physiological membrane potentials. 
Overall, the INa activation and inactivation properties in EndoC-βH1 and -βH2 cells are similar to those observed 
in primary human beta-cells23,28.
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Figure 2. KATP channel activity and action potential firing. (a) Representative membrane potential recording 
made in EndoC-βH1 (top) and EndoC-βH2 (lower) at 1 and 20 mmol/L glucose (as indicated). (b) Action 
potential frequency in EndoC-βH1 and -βH2 cells at 1 and 20 mmol/L glucose. *p < 0.05 (1 mmol/L glucose 
n = 5 cells each, 20 mmol/L glucose n = 3 and 4 cells for EndoC-βH1 and -βH2, respectively). Student’s t-test. 
(c) Examples of average action potentials (AP) recorded in two EndoC-βH1 cells, and EndoC-βH2 cell and a 
primary human beta-cell as indicated (average of at least 12 and 15 APs from the same recording). (d) Resting 
KATP channel activity in EndoC-βH1 and -βH2 cells measured at 1 mmol/L glucose (n = 22 and 21 cells). (e) 
Effects of glucose, tolbutamide and diazoxide (added at the indicated concentrations) on whole-cell KATP 
channel activity. KATP channel activity has been normalised to that at 1 mmol/L glucose. *vs. 1 mmol/L and #vs. 
20 mmol/L glucose. * and #p < 0.05, **p < 0.01, and ***p < 0.001, paired t-test. Number of cells (n) is inserted 
in the corresponding columns. (f) Cell capacitance in EndoC-βH1 and -βH2 cells *p < 0.05 (n = 30 and 32 cells 
respectively). Student’s t-test.
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Figure 3. Voltage-gated Na+ currents. (a) Voltage-gated Na+ currents (INa) in EndoC-βH1 (left) and -βH2 cells 
(right) in the presence of Co2+ (1 mmol/L) with or without TTX (0.1 μg/ml; as indicated) during depolarisations 
from −70 to 0 mV (representative of 24 and 11 cells for EndoC-βH1 and -βH2 respectively). (b) Families of 
INa recorded during depolarisations from −70 (left) and −150 mV (right) during depolarisations to indicated 
membrane potentials. (c) INa current-voltage relationships recorded from a holding potential of −70 or −150 mV 
in EndoC-βH1 (upper panel; n = 24 cells) and -βH2 cells (lower panel; n = 11 cells). Current responses normalised 
to the peak current elicited by a depolarisation from −70 mV to 0 mV. (d) INa activation when cells were held at 
−70 mV in EndoC-βH1 and -βH2 cells. Curves were derived by fitting Eq. 1. to current responses of individual 
experiments (n = 26 − 23 cells). (e) Steady-state voltage-dependent inactivation of INa in EndoC-βH1 (red) and -βH2 
cells (black) estimated from a two-pulse protocol: a standard test pulse to 0 mV was preceded by 50 ms conditioning 
pulse to membrane potentials between −150 and 0 mV (n = 26 and 32 cells). Data have been normalised to the 
maximum current during the test pulse (h∞ = I/Imax). Responses have been fitted to Eq. 2. (f) INa evoked by action 
potential-like voltage-clamp commands in EndoC-βH1 (black; n = 26 cells) and -βH2 cells (red; n = 32 cells).
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Figure 3c shows INa during an action potential-like voltage-clamp stimulation (based on the action potentials 
recorded in EndoC-βH2 cells). Peak INa elicited by this stimulation paradigm were small: 3.1 ± 0.3 pA.pF−1 and 
3.9 ± 1 pA.pF−1 in EndoC-βH1 and -βH2 cells, respectively (Fig. 3f).
At the mRNA level and compared to the gene set of Na+ channels transcripts EndoC-βH1 and -βH2 cells 
express particularly high levels of SNC8A (Nav1.6) and SNC9A (Nav1.7). SCN3A (Nav1.3) is also highly expressed 
in EndoC-βH2 cells. Furthermore, SCN5A and SCN7A are expressed at relatively high levels but these encode 
TTX-resistant channels. Given that INa in both cell types is TTX-sensitive, it appears that these transcripts do not 
give rise to functional channels. Of the β-subunits, only SCN3B is expressed at significant levels (Supplementary 
Fig. 2, and Supplementary dataset).
Ca2+ channels. Voltage-gated Ca2+ currents (ICa) were recorded in the presence of TTX. The relative contribu-
tion of P/Q-, L- and R-type Ca2+ channels was estimated by sequential addition of ω-agatoxin, isradipine and 
SNX482 in presence of TTX to inhibit INa+(Fig. 4a,c). Figure 4b,d compares the voltage dependence of the total 
ICa and the different (pharmacologically isolated) ICa components (EndoC-βH1, n = 5; EndoC-βH2, n = 3 cells). 
In both cell lines, there was a ‘shoulder’ at voltages between −50 and −20 mV. In both cell types, P/Q-type Ca2+ 
channels accounted for ~60% of the total current, whereas L- and R-type Ca2+ channels contributed 20–30% 
Figure 4. Voltage-gated Ca2+ currents. (a,c) Voltage-gated Ca2+ currents (ICa) evoked by membrane 
depolarisations between −70 and 0 mV under control conditions and following sequential addition of 
ω-agatoxin (200 nmol/L), isradipine (10 μmol/L) and SNX482 (100 nmol/L) in EndoC-βH1 (a) and EndoC-βH2 
(C). (b,d) Current voltage relationships normalised to maximum peak total current in each cell for the total 
ICa and the isolated P/Q (ω-agatoxin-sensitive), L- (isradipine-sensitive) and R-type (SNX482-sensitive) 
components in EndoC-βH1 (b) and EndoC-βH2 (d). (e,f) Current density (peak amplitude normalised to cell 
capacitance) histograms showing the maximum total as well as pharmacologically isolated R-, L- and P/Q-type 
Ca2+ current components in EndoC-βH1 (e) and EndoC-βH2 (f). (g) ICa evoked in EndoC-βH2 cells using a 
voltage-clamp command based on action potentials recorded in these cells. The traces shown correspond to 
the total ICa as well as the isolated P/Q-, L- and R-type components. Data are based on measurements in 5 and 3 
cells for EndoC-βH1 and -βH2 respectively.
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and 5–10%, respectively (Fig. 4b,d). Similar to previous measurements on primary human beta-cells23, the total 
ICa density was ~10 pA/pF in both cell types (Fig. 4e). Figure 4g compares the activation of the total ICa and the 
respective components during an action potential in EndoC-βH2 cells. It is clear that both the L- and P/Q-type 
Ca2+ channels activate during the brief action potential.
Consistent with electrophysiology, transcriptomic profiling revealed high expression of CACNA1A (P/Q-type) 
and CACNA1C/D (L-type) Ca2+ channels and low levels of CACNA1E (R-type) expression. Moreover, CACNA1H 
(T-type) Ca2+ channels are expressed at high levels and are likely to account for the shoulder between −50 and 
−20 mV in the current-voltage relationships (Fig. 4a,c). Of the auxiliary subunits, high expression of CACNG4 
(γ4), CACNA2D (α2δ2) and CACNB1-3 (β1-β3) was observed (Supplementary Fig. 3; and Supplementary dataset).
K+ channels. Voltage-activated K+-currents (IK) elicited during membrane depolarisations from −70 mV to 
membrane potentials between −20 and +70 mV in EndoC-βH1 and -βH2 cells are shown in Fig. 5a. The ampli-
tude of IK increased linearly with the applied voltage and the density was ~50% larger in EndoC-βH2 (n = 3) than 
in -βH1 (n = 4 cells) (Fig. 5b). We estimated the contribution of voltage- (Kv2) and Ca2+-activated (BK) channels 
to IK by sequential addition of their cognate blockers stromatoxin and iberiotoxin respectively (Fig. 5c). Notably, 
BK channels played a more prominent role in EndoC-βH2 than in EndoC-βH1 during depolarisations to −10 
and 0 mV (Fig. 5d). Figure 5e shows the contribution of KV2 and BK channels to the outward current during 
voltage-clamp depolarisations based on the action potentials in EndoC-βH1 and -βH2 cells. This analysis reveals 
that BK current component activated rapidly during the action potential and at a time when no outward current 
was seen in the EndoC-βH1 cells (Fig. 5e, vertical dashed line).
The transcript profile of the K channels expressed in EndoC-βH1 and -βH2 cells reveals high levels of the KV2 
channel genes KCNH6, H2, KCNB2, KCNQ2 and the BK channel genes KCNMA1 and KCNMB3 (Supplementary 
Fig. 4 and Supplementary dataset).
Exocytosis. Depolarisation-evoked exocytosis was monitored as increases in cell capacitance. Figure 6a,b 
compares the voltage dependence of exocytosis. Exocytosis was trigged by 500 ms depolarisations to voltages 
between −40 and +40 mV. In both cell types, exocytosis was elicited at voltages above −30 mV, was maximal at 
~0 mV and declined at more depolarised voltages (EndoC-βH1, n = 6; EndoC-βH2, n = 10 cells). This voltage 
dependence echoes that of ICa. The kinetics of exocytosis during depolarisation to 0 mV (i.e. close to the peak of 
the action potential) was determined by application of progressively longer depolarisations (Fig. 6c,d). In both 
EndoC-βH1 and -βH2 cells, exocytosis was elicited by depolarisations as short as 20 ms, showed an initial pla-
teau between 50 and 100 ms and a secondary acceleration during longer depolarisations (EndoC-βH1 n = 12; 
EndoC-βH2 n = 14 cells). The exocytotic response to a 800 ms depolarisation once the capacitance had stabilized 
was 119 ± 31 fF and 181 ± 40 fF in EndoC-βH1 and -βH2 respectively (Fig. 6d, insert).
We also monitored exocytosis during repetitive stimulation consisting of ten 500 ms depolarisations to 0 mV 
(Fig. 6e). Figure 6f compares the responses to the individual depolarisations in EndoC-βH1 (n = 12 cells) and 
-βH2 (n = 14 cells). The kinetics of exocytosis was biphasic, echoing the kinetics observed in primary human 
beta-cells29. The largest response was elicited by the initial depolarisations with the first two pulses accounting 
for ≥50% of the total increase in capacitance and the responses during the last four pulses were small. The total 
increase in cell capacitance evoked by the train averaged 450 fF in both cell types (Fig. 6f, inset).
Transcriptomic analysis of genes encoding proteins involved in exocytosis revealed higher expression of 
SNAP25 in EndoC-βH1, than in EndoC-βH2 cells. The other SNAREs, VAMP2 and Syntaxin1A (STX1A) were 
expressed to the same extent (Supplementary Fig. 5 and Supplementary dataset). Other components of the exo-
cytotic machinery, including munc18a-c (STXBP1-3), munc13b (UNC13B) and the complexins (CPLX1-2) were 
also highly expressed. Of the Ca2+ sensors of exocytosis, the high-affinity Ca2+ sensor SYT7 was the predominant 
synaptotagmin in both cell types but relatively high levels of SYT1, 5 and 9 were also detected in EndoC-βH1 cells.
Subset of EndoC-βH1 and -βH2 cells are polyhormonal cells. Ultrastructural analysis revealed that 
the secretory granules in EndoC-βH1 and -βH2 were of variable size and that most granules exhibited a clear 
thin halo and a central insulin-containing core (Fig. 7a). The granule density (granules per cytoplasm area; NA) 
was slightly higher in EndoC-βH2 cells than in the -βH1 cells (Fig. 7b, n = 10 cells in both cell types, p = 0.045) 
but the intragranular insulin density (estimated from immunogold labelling) was correspondingly reduced 
(p = 9.1 × 10−8) (Fig. 7c). On average, 4.5 ± 1.7% (EndoC-βH1) and 7.6 ± 2.4% (EndoC-βH2) of the vesicles per 
EM section were directly docked to the plasma membrane. In both cell types, the cross-sectional granule area was 
0.03 µm2 (Fig. 7d; n = 265 and 337 vesicles in EndoC-βH1 and -βH2 respectively), corresponding to a granule 
diameter of 200 nm from which we estimate a granule surface area of 0.12 µm2 (assuming spherical geometry).
Immunocytochemistry suggested that most EndoC-βH1 and -βH2 cells contained only insulin-labelled 
granules but that a small subset of cells also contained somatostatin- and/or glucagon-positive granules 
(Supplementary Fig. 6). Whereas insulin- and glucagon-positive cells were found only in EndoC-βH2, 
somatostatin-positive cells were found in both cell lines. Electron microscopy in conjunction with immunogold 
labelling indicated that somatostatin and insulin could be contained in the same granules (Fig. 7e). Transcript 
analysis confirmed high expression of insulin (INS) in both EndoC-βH1 and -βH2 cells and that glucagon (GCG) 
and somatostatin (SST) were expressed at particularly high levels in EndoC-βH2 cells. There was also high 
expression of the somatostatin receptors 1, 2 and 3 (SSTR1-3) (Supplementary Fig. 7 and Supplementary dataset). 
Notably, addition of the SSTR2 antagonist CYN154806 doubled glucose-induced insulin secretion in EndoC-βH2 
cells (p = 0.035) (Fig. 7f).
Transcriptome and foetal origin. The relative low stimulation of insulin secretion and the polyhormonal-
ity observed in EndoC-βH2 cells may be remaining features from their foetal origin30,31. To address this question, 
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Figure 5. Voltage-gated K+ currents. (a) Families of voltage-gated K+ currents (IK) in EndoC-βH1 (left) and 
EndoC-βH2 (right) during voltage steps from −70 mV to membrane potentials between −20 and +40 mV. (b) 
Current density-voltage relationships in EndoC-βH1 (black) and EndoC-βh2 (red). Current density recorded 
in both cell lines at 0 mV, inset. (c) IK recorded during membrane depolarisations to 10 mV under control 
conditions, after addition of stromatoxin (Stx, 100 nmol/L) and iberiotoxin (Ibtx, 100 nmol/L) as indicated. 
Bottom panels show pharmacologically isolated KV2 (Stx-sensitive) and BK Ibtx-sensitive) current components. 
(d) Voltage dependence of KV2 and BK currents. Responses have been normalised to peak total IK at +50 mV. 
(e) IK evoked in EndoC-βH1 and -βH2 cells using voltage-clamp commands based on the action potentials 
recorded in the respective cells under control conditions and the isolated Stx- and Ibtx-sensitive components. 
Data are based on measurements in n = 4 EndoC-βH1 cells and n = 3 EndoC-βH2 cells.
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Figure 6. Voltage dependence and kinetics of exocytosis. (a,b) Exocytosis evoked by 500 ms depolarisations 
from −70 mV to indicated membrane potentials (top) in EndoC-βH1 (black) and EndoC-βH2 cells (red). 
(b) Voltage dependence of exocytosis in EndoC-βH1 (black; n = 6 cells) and EndoC-βH2 cells (red; n = 10 
cells). Responses are normalised to maximum response. (c,d) Exocytosis evoked by progressively longer 
(10–800 ms) depolarisations from −70 to 0 mV. (d) Relationship between pulse duration and exocytotic 
response in EndoC-βH1 (black; n = 12 cells) and EndoC-βH2 cells (red; n = 14 cells). Exocytosis is normalised 
to the response evoked by the 800 ms depolarisation (inset). (e,f) Representative trace of exocytosis evoked by 
trains of ten 500 ms depolarisations from −70 to 0 mV in EndoC-βH1 (black) and EndoC-βH2 cells (red). (f) 
Exocytotic response during the individual depolarisations in EndoC-βH1 (black, n = 12 cells) and EndoC-βH2 
cells (red, n = 14 cells). Responses are normalised to the total increases in cell capacitance evoked by the trains 
in individual cells (inset).
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Figure 7. Ultrastructural analysis. (a) Electron micrograph of immunogold- labeled insulin (15 nm gold 
particles) in EndoC-βH1 (left) and EndoC-βH2 cells (right). Abbreviations: SG, Secretory Granule; PM, Plasma 
Membrane; N, Nucleus. Scale bar: 1 µm. (b–d) Quantification of the granule density (NA, number of granule per 
cytoplasmic area; (b), number of immunogold particles per SG (c) and granule cross-sectional area (d). Data in 
(a–d) representative for 10 cells of each type.*p < 0.05 and ***p < 0.001 (Student’s t-test) (e) Some EndoC-βH2 
cells have SG containing both insulin (10 nm gold particles) and somatostatin (15 nm gold particles). See also 
Supplementary Figure S6. Abbreviations: Ins, insulin; SST, somatostatin. Scale bar: 0.25 µm. (f) Potentiation of 
insulin secretion at 20 mmol/L glucose by the SSTR antagonist CYN154806 (1 µM). *P < 0.05, Student’s t-test 
(n = 3 independent experiments).
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we compared the publically available transcriptomic data from foetal and adult human pancreatic beta cells with 
the RNA sequencing datasets we generated from EndoC-βH1 and -βH2 cell lines. We analysed a subset of genes 
that were consistently lowly or not expressed in human adult beta cells but highly expressed in foetal beta cells32,33. 
Such genes encoded for either components of the early development (NGN3 (Neurogenin 3)) or the inflamma-
tory response (PTGS2 (Prostaglandin-Endoperoxide Synthase 2), S100A9 (S100 Calcium Binding Protein), and 
DEFA4 (Defensin Alpha 4))32. Comparison of a subset of genes known to be mainly expressed in human foetal 
beta cells revealed that the human beta cell lines’ transcriptomes are closer to the one of an adult primary beta cell 
(Supplementary Fig. 9).
Discussion
We have characterised the electrophysiological properties of two human beta-cell lines: EndoC-βH1 and -βH2. 
We confirmed that both cell lines are glucose-responsive with the stimulatory effect on insulin secretion lim-
ited to a 2- to 3-fold enhancement8–10. At the transcriptional level, these cell lines exhibit a greater similarity to 
adult than to foetal human beta cells. We acknowledge that these human beta-cell lines exhibit some variability 
between different batches in terms of glucose responsiveness of insulin secretion and even presence of ion chan-
nels. However, this is not unique to these cell lines and, provided appropriate controls are performed in parallel, 
this variability should be possible to manage. In this context it is worth remembering that also primary human 
islets show significant inter-preparation variability. Here we discuss a few aspects of this work that we find par-
ticularly interesting and important. We correlate our findings in the EndoC-βH1 and EndoC-βH2 cell lines to 
what has previously been found for primary human beta-cells.
KATP channel activity and action potential firing. The action potentials induced by glucose originated 
from a membrane potential of ~−50 mV and usually peaked at +5 mV (or above). Both EndoC-βH1 and -βH2 
are equipped with KATP channels. The measured KATP channel density at 1 mmol/L glucose in metabolically intact 
beta-cells is 0.05 nS/pF. As the cells had cell capacitances of 10–12 pF, these values correspond to a resting con-
ductance of ~0.5 nS and an input resistance (the reciprocal of the resting conductance) as high as 2 GΩ. The 
former value is only ~10% of the corresponding value in mouse beta-cells but comparable to that observed in 
primary human beta-cells1. The high input resistance suggests that small currents (such as those resulting from 
the opening of individual ion channels) may produce a membrane depolarisation large enough to trigger an 
action potential. This probably explains why EndoC-βH1 and -βH2 cells generate spontaneous action potentials 
and exhibit [Ca2+]i transients at 1 mmol/L glucose.
Both increasing glucose (to 6 and 20 mmol/L) and application of the KATP channel inhibitor tolbutamide 
reduced the resting conductance by 50–60%. Thus, it appears that the net KATP density is ~0.03 nS/pF with the 
rest representing the contribution of other ion channels (or ‘leak’ around the recording electrode). The inhibitory 
effect of glucose could be reversed by diazoxide and the input conductance measured in the presence of this KATP 
channel activator was 3- to 6-fold that measured in the presence of glucose alone in EndoC-βH1 and -βH2 cells, 
respectively.
The finding that high glucose and tolbutamide inhibit KATP channel activity and stimulate insulin secretion 
similarly should not be taken to indicate that glucose solely operates by the triggering (KATP channel-dependent) 
mechanism with little involvement of the amplifying (KATP channel-independent) mechanism. On the contrary, 
our recordings of the cytosolic [Ca2+]i show that tolbutamide stimulates a greater number of cells than glucose 
does, suggesting that tolbutamide exerts a weaker stimulatory effect when normalised to the number of cells 
activated.
Voltage-gated ion channels. We found that the EndoC-βH1 and -βH2 cells express voltage-gated ion 
channel counterparts very similar to that found in primary human beta-cells23. Thus, action potential firing in 
these human beta-cell lines involves activation of voltage-gated Na+, Ca2+ and K+ channels34. Interestingly, most 
of EndoC-βH1 cells exhibit large-amplitude and long-duration action potentials. Using voltage-clamp com-
mand pulses based on recorded glucose-induced action potentials, we found that this correlated with delayed 
and reduced activation of an iberiotoxin-sensitive K+ current (reflecting the opening of large-conductance 
Ca2+-activated K+ channels; BK) and slower action potential repolarisation. The same analysis also suggests that 
Kv2 channels play a relatively more prominent role in action potential repolarisation in these cell lines than in 
human primary beta cells23. Voltage-clamp analyses of the current responses further suggest that potential depo-
larisation principally reflects opening of voltage-gated P/Q- and L-type Ca2+ channels with little contribution by 
voltage-gated Na+ channels. This is because action potentials originate from fairly depolarised membrane poten-
tials (−55 to −50 mV). At these membrane potentials, the Na+ channels are largely inactivated, which explains 
why INa contributes only marginally to action potential firing at steady-state.
Correlating electrophysiology with gene expression. To establish how authentic EndoC-βH1 and 
-βH2 cells are as models of primary human beta-cells, we correlated the electrophysiological data with gene 
expression. We found that there was, in general, good agreement at the transcript level between both cell lines and 
primary human beta-cells. Among the voltage-gated Na+ channels, SCN8A (Nav1.6) and SCN9A (Nav1.7) are 
expressed at particularly high levels. We detected high expression of L-type Ca2+ channel α-subunits CACNA1C 
(α1C), CACNA1D (α1D) and P/Q-type Ca2+ channels CACNA1A. Furthermore, very high expression of the 
T-type Ca2+ channel CACNA1H was detected. Expression of CACNA1E and CACNA1B (encoding R- and N-type 
Ca2+-channels, respectively) were low in EndoC-βH1 and -βH2 cells (echoing what is seen in primary human 
beta-cells23,33).
Of the voltage-gated K+ channels, KCNB2 (Kv2.2), KCNQ2 (Kv7.2) and KCNH2 (Kv11.1) are expressed at 
particularly high levels, mirroring what is seen in human beta-cells33. High expression was also observed for the 
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BK α-subunit gene KCNMA1. However, despite the evidence for reduced BK activity in EndoC-βH1 cells com-
pared to EndoC-βH2 cells, mRNA levels were comparable between the two cell lines. Overall, the expression of 
these voltage-gated ion channels in EndoC-βH1 and -βH2 cells mirror that seen in primary human beta-cells32,33.
Correlating ultrastructure, exocytosis and insulin secretion. Using immunofluorescence as well as 
electron microscopy, we show that both cell lines are well granulated, although the granules are not evenly distrib-
uted within the cell. The secretory granules are found at higher density in cytoplasmic projections (Supplemental 
Figs 6–8). Granules are morphologically heterogeneous with a majority characterised by a very thin halo sur-
rounding the electron dense core (insulin). The granule density (NA) can be converted to the volume density (NV) 
(Eq. 3) and corresponded to ~13 and 20 granules.μm−3 in EndoC-βh1 and βh2, respectively. When multiplied by 
the extranuclear cell volume, these values convert to ~6,000 and 15,000 secretory granules/cell in EndoC-βH1 
and -βH2 cells, respectively. This is not too different from the numbers found in primary beta-cells35,36. Given 
that between 4 to 7% of the vesicles appeared to be directly in contact with the plasma membrane, we estimate 
the docked granule pool is of 250–650 vesicles, in fair agreement the 600 docked granules estimated in human 
primary beta cells2,37.
Exocytosis. The measurements of exocytosis also indicate that the late steps of insulin release largely reca-
pitulate what is observed in primary beta-cells. However, EndoC-βH1 cells could be distinguished from the 
EndoC-βH2 cells by the kinetics of secretion. Whereas most of exocytosis in the EndoC-βH2 cells occurred 
during the actual depolarisation (‘phasic exocytosis’), exocytosis in many EndoC-βH1 cells occurred after the 
depolarisation and when the membrane potential had returned to −70 mV (‘asynchronous exocytosis’). This sug-
gests that the kinetics of exocytosis in EndoC-βH1 mirrors the depolarisation-evoked [Ca2+]i transients, which 
typically takes a few seconds to return to basal38. This is consistent with the high expression of the high-affinity 
Ca2+-sensor synaptotagmin 7 (SYT7) in EndoC-βH1 cells. However, this cannot be the sole explanation as equally 
high expression of SYT7 is seen in EndoC-βH2 cells and yet exocytosis was ‘phasic’.
Quantitatively, the exocytotic responses observed in EndoC-βH1 and -βH2 cells are impressive. A single 
800 ms depolarisation produced a capacitance increase of 100 and 180 fF in EndoC-βH1 and -βH2 cells, respec-
tively. The granule area estimated from electron microscopy was 0.12 µm2. With a specific capacitance of 10 
fF.μm−2, this granule area predicts that each granule should add 1.2 fF of capacitance upon fusion. Thus, the exo-
cytotic responses equate to the discharge of 80–150 granules, which corresponds to 15–25% of the docked vesicles 
pool and ~1% of the total granule number. This echoes the size of the Ready Releasable Pool (RRP, ~200 vesicles) 
described in human pancreatic beta cells37. From the relationship between pulse duration and exocytosis, we 
estimate that a 10 ms depolarisation (the approximate duration of an action potential) will produce an exocytotic 
response of ≤1% of that produce by the 800 ms pulse (Fig. 5). Thus, we can estimate that each action potential will 
(on average) result in the release of 0.8–1.5 granules. Multiplying these values with the observed action potential 
frequency (1.45 Hz) suggests that EndoC-βH1 and -βH2 cells release an astonishing 100% and 50% of their total 
insulin content per hour. However, the [Ca2+]i measurements suggest that only 20–25% of the cells respond to 
glucose. This implies that EndoC-βH1 and -βH2 respectively release about 20% and 10% of their insulin content 
per hour, in fair agreement with the secretion rates actually observed.
Impact of ‘polyhormonality’. At the mRNA level, glucagon and somatostatin levels equal that of insulin in 
EndoC-βH2. However, at the protein level only a relatively small fraction of cells are polyhormonal. Immunogold 
labelling in conjunction with electron microscopy revealed that these cells could store both insulin and somato-
statin within the same granules. Interestingly, there was also relatively high expression of the somatostatin recep-
tors 1, 2 and 3 (SSTR1-3), raising the possibility of autocrine inhibition. Indeed, when the cells were treated with 
1 μmol/L CYN154806, glucose-induced insulin secretion was doubled. As this antagonist is selective for SSTR2, it 
is possible that even greater enhancement would have been observed if SSTR1 and SSTR3 had also been targeted.
Conclusion
We conclude that both EndoC-βH1 and -βH2 cells are reliable models of primary human beta-cells. We 
acknowledge that the secretory response to glucose and tolbutamide appears relatively limited and subjected 
to batch-to-batch variations. This is illustrated by the variable GSIS fold stimulation at high glucose reported in 
different studies8,21,39 which could even approach that seen in primary beta-cells16. Electrophysiologically, both 
EndoC-βH1 and -βH2 cells closely mirror primary human beta-cells both at the functional and the gene expres-
sion levels. Our detailed characterisation of both cell lines demonstrates that they represent versatile models of 
primary human beta-cells which can be used for high-throughput pipelines18,21 as well as detailed in vitro studies 
of the insulin secretory defects19,40. The fact that they are relatively easy to modify genetically makes them an 
attractive and powerful tool for future investigations of the relationship between gene expression and beta-cell 
function.
Data Availability
The transcriptomic datasets generated during and analysed during the current study are available in the at the 
European Nucleotide Archive (https://www.ebi.ac.uk/ena) under the accession number PRJEB23293 (a summary 
of the transcriptome analysis can also be found in Supplementary dataset).
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